Quick Answer
TG THERAPEUTICS, INC. reported Total Assets of $1.06 billion for the year ending 2025.
- TG THERAPEUTICS, INC. showed an increase of +84.1% in Total Assets from 2024 to 2025.
- This data is from TG THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2010: $18.64 million | Q3 2011: $18.06 million | Q1 2012: $27.07 million | Q3 2012: $25.23 million | Q2 2013: $17.86 million | Q3 2013: $54.30 million | Q1 2014: $58.17 million | Q2 2014: $56.30 million | Q3 2014: $77.54 million | Q1 2015: $117.27 million | Q2 2015: $123.61 million | Q3 2015: $127.41 million | Q1 2016: $100.06 million | Q2 2016: $94.80 million | Q3 2016: $75.69 million | Q1 2017: $123.26 million | Q2 2017: $101.20 million | Q3 2017: $101.78 million | Q1 2018: $120.99 million | Q2 2018: $140.72 million | Q3 2018: $114.37 million | Q1 2019: $117.54 million | Q2 2019: $106.59 million | Q3 2019: $93.33 million | Q1 2020: $101.85 million | Q2 2020: $294.62 million | Q3 2020: $273.86 million | Q1 2021: $548.70 million | Q2 2021: $481.40 million | Q3 2021: $409.69 million | Q1 2022: $303.03 million | Q2 2022: $251.67 million | Q3 2022: $217.89 million | Q1 2023: $197.36 million | Q2 2023: $220.85 million | Q3 2023: $331.07 million | Q1 2024: $373.32 million | Q2 2024: $401.21 million | Q3 2024: $586.01 million | Q1 2025: $656.69 million | Q2 2025: $702.61 million | Q3 2025: $1.03 billion.
- Over the full 15 years of available data (2011 to 2025), TG THERAPEUTICS, INC.'s Total Assets has grown by 7,213.9%.
- Historical annual values: Fiscal year 2025: $1.06 billion | Fiscal year 2024: $577.69 million | Fiscal year 2023: $329.59 million | Fiscal year 2022: $193.57 million | Fiscal year 2021: $379.63 million | Fiscal year 2020: $625.64 million | Fiscal year 2019: $163.01 million | Fiscal year 2018: $83.62 million | Fiscal year 2017: $97.38 million | Fiscal year 2016: $54.78 million | Fiscal year 2015: $113.47 million | Fiscal year 2014: $86.75 million | Fiscal year 2013: $48.11 million | Fiscal year 2012: $22.07 million | Fiscal year 2011: $14.54 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: